Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mirati Therapeutics (MRTX)

Mirati Therapeutics (MRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mirati Therapeutics 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 USA

P: 858-332-3410

Description:

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.

Key Statistics

Overview:

Market Capitalization, $K 3,776,392
Shares Outstanding, K 39,436
Annual Sales, $ 12,930 K
Annual Net Income, $ -98,420 K
Last Quarter Sales, $ 990 K
Last Quarter Net Income, $ -54,270 K
60-Month Beta 2.05
% of Insider Shareholders 4.86%
Float, K 37,519
% Float 95.14%

Growth:

1-Year Return 133.61%
3-Year Return 1,551.03%
5-Year Return 546.15%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 31.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/05/19
Earnings Per Share ttm -4.68
EPS Growth vs. Prev Qtr -9.52%
EPS Growth vs. Prev Year -62.35%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

MRTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -14.90
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -48.60
Return-on-Assets (Before Tax) -44.81
Profit Margin % -761.18
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 282.61
Price/Cash Flow N/A
Price/Book 9.36
Book Value/Share 11.02
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar